Patent ID: 9511058
Filing Date: 2016-12-06
CPC Classification: A61K,A61P

Claim Text:
1. A method for treating or ameliorating a disorder or condition selected from exercise intolerance resulting from mitochondrial dysfunction, chronic fatigue syndrome resulting from mitochondrial dysfunction, muscle weakness resulting from mitochondrial dysfunction, myoclonus resulting from mitochondrial dysfunction, myoclonus epilepsy, Kearns-Sayre syndrome, Leigh's syndrome, mitochondrial myopathy encephalopathy lactacidosis stroke (MELAS) syndrome, and intermittent claudication in a subject, the method comprising administering to the subject an effective amount of a compound having the structural formula or a pharmaceutically acceptable salt or N-oxide thereof, wherein each R w is 0, 1, 2 or 3; R each R x is 0, 1, 2, 3 or 4; each Q is —CH the ring system denoted by “A” is monocyclic heteroaryl or phenyl; each R y is 0, 1, 2, 3 or 4; each R v is 0, 1, 2, 3 or 4; G is —CH R in which